Efficacy and Safety of Oral Anticoagulants for Atrial Fibrillation Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis

Tae‐Min Rhee; So-Ryoung Lee; Eue-Keun Choi; Seil Oh; Professor Gregory Lip

doi:10.3389/fcvm.2022.885548

Back

Related publications

Article2025

Efficacy and Safety of Direct Oral Anticoagulants for Patients With Atrial Fibrillation With Glomerular Hyperfiltration: A Systematic Review and Meta-Analysis

Xinyi Gao, Ziheng Jia, Gary Tse, Professor Gregory Lip, Tong Liu

Article2022

The management of anticoagulants in patients with atrial fibrillation and history of falls or risk of falls: protocol for a systematic review and meta-analysis

Thibaut Galvain, Ruaraidh Hill, Sarah Donegan, Paulo Lisboa, Professor Gregory Lip, Gabriela Czanner

Article2021

Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of 605 771 patients

Danilo Menichelli, Francesco Del Sole, Arianna Di Rocco, Alessio Farcomeni, Annarita Vestri, Francesco Violi, Pasquale Pignatelli, Professor Gregory Lip, Daniele Pastori

Article2024

Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studies

Katarzyna Nabrdalik, Mirela Hendel, Krzysztof Irlik, Hanna Kwiendacz, Igor Łoniewski, Tommaso Bucci, Uazman Alam, Professor Gregory Lip, Janusz Gumprecht, Karolina Skonieczna‐Żydecka

Article2020

Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus

Professor Gregory Lip, Allison Keshishian, Amiee Kang, Xiaoyan Li, Amol D. Dhamane, Xuemei Luo, Neeraja Balachander, Lisa Rosenblatt, Jack Mardekian, Anagha Nadkarni, Xianying Pan, Manuela Di Fusco, Alessandra Bassalobre García, Hüseyin Yüce, Steven Deitelzweig